[go: up one dir, main page]

DE60037602D1 - Herstellung einer polymorphen Form eines Thiazolidindionderivates - Google Patents

Herstellung einer polymorphen Form eines Thiazolidindionderivates

Info

Publication number
DE60037602D1
DE60037602D1 DE60037602T DE60037602T DE60037602D1 DE 60037602 D1 DE60037602 D1 DE 60037602D1 DE 60037602 T DE60037602 T DE 60037602T DE 60037602 T DE60037602 T DE 60037602T DE 60037602 D1 DE60037602 D1 DE 60037602D1
Authority
DE
Germany
Prior art keywords
preparation
polymorphic form
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60037602T
Other languages
English (en)
Other versions
DE60037602T2 (de
Inventor
Paul David James Blackler
Robert Gordon Giles
Michael John Sasse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60037602(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909472.4A external-priority patent/GB9909472D0/en
Priority claimed from GBGB9912197.2A external-priority patent/GB9912197D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE60037602D1 publication Critical patent/DE60037602D1/de
Application granted granted Critical
Publication of DE60037602T2 publication Critical patent/DE60037602T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE60037602T 1999-04-23 2000-04-19 Herstellung einer polymorphen Form eines Thiazolidindionderivates Expired - Fee Related DE60037602T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9909472.4A GB9909472D0 (en) 1999-04-23 1999-04-23 Novel compounds
GB9909472 1999-04-23
GBGB9912197.2A GB9912197D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
GB9912197 1999-05-25

Publications (2)

Publication Number Publication Date
DE60037602D1 true DE60037602D1 (de) 2008-02-07
DE60037602T2 DE60037602T2 (de) 2009-01-08

Family

ID=26315460

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60037602T Expired - Fee Related DE60037602T2 (de) 1999-04-23 2000-04-19 Herstellung einer polymorphen Form eines Thiazolidindionderivates
DE60004658T Expired - Fee Related DE60004658T2 (de) 1999-04-23 2000-04-19 Thiazolidindionderivat und seine verwendung als antidiabetikum

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60004658T Expired - Fee Related DE60004658T2 (de) 1999-04-23 2000-04-19 Thiazolidindionderivat und seine verwendung als antidiabetikum

Country Status (40)

Country Link
US (2) US6815457B1 (de)
EP (3) EP1284268B1 (de)
JP (1) JP2002543075A (de)
KR (1) KR100744359B1 (de)
CN (1) CN1208335C (de)
AP (1) AP1495A (de)
AR (2) AR023568A1 (de)
AT (2) ATE247653T1 (de)
AU (1) AU765498B2 (de)
BG (1) BG65427B1 (de)
BR (1) BR0009934A (de)
CA (1) CA2370258A1 (de)
CO (1) CO5170424A1 (de)
CY (1) CY1107238T1 (de)
CZ (1) CZ20013799A3 (de)
DE (2) DE60037602T2 (de)
DK (2) DK1173434T3 (de)
DZ (1) DZ3155A1 (de)
EA (1) EA004534B1 (de)
ES (2) ES2298327T3 (de)
HK (1) HK1045154B (de)
HR (1) HRP20010773B1 (de)
HU (1) HUP0200929A3 (de)
IL (1) IL146110A0 (de)
MA (1) MA26785A1 (de)
MX (1) MXPA01010820A (de)
MY (1) MY128007A (de)
NO (1) NO320589B1 (de)
NZ (1) NZ515163A (de)
OA (1) OA11871A (de)
PE (1) PE20010040A1 (de)
PL (1) PL351686A1 (de)
PT (2) PT1284268E (de)
RS (1) RS50114B (de)
SK (1) SK286423B6 (de)
TR (1) TR200103061T2 (de)
TW (1) TW591027B (de)
UA (1) UA67843C2 (de)
UY (1) UY26120A1 (de)
WO (1) WO2000064892A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
AR023561A1 (es) * 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
DE60037602T2 (de) 1999-04-23 2009-01-08 Smithkline Beecham P.L.C., Brentford Herstellung einer polymorphen Form eines Thiazolidindionderivates
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
NZ525498A (en) * 2000-09-26 2004-11-26 Reddys Lab Ltd Dr Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003053962A1 (en) * 2001-12-20 2003-07-03 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (de) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphe Formen von Rosiglitazon Maleat
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (de) * 2004-01-28 2006-10-11 Usv Limited Verfahren zur herstellung von 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]phenylmethyl]thiazolidin-2,4-dionmaleat
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (de) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung fester Dosierungsformen von Rosiglitazonmaleat

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (de) 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
US6288095B1 (en) 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
EP0777469A1 (de) 1994-02-10 1997-06-11 Smithkline Beecham Plc Verwendung von insulin-sensibilisierenden wirkstoffe zur behandlung der nierenkrankheiten
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US20010044458A1 (en) * 1994-02-10 2001-11-22 Smithkline Beechamp P.L.C. Use of insulin sensitisers for treating renal diseases
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US6153632A (en) * 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
WO1998057634A1 (en) 1997-06-18 1998-12-23 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and metformin
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
GB9712866D0 (en) 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
EP0975343A1 (de) 1997-06-18 2000-02-02 Smithkline Beecham Plc Behandlung der diabetes mit thiazolidindione und alpha-glukosidaseinhibitor
ATE353654T1 (de) 1997-06-18 2007-03-15 Smithkline Beecham Plc Behandlung der diabetes mit thiazolidindione und sulphonylurea
US20020028768A1 (en) * 1997-06-18 2002-03-07 Smithkline Beecham P.L.C. Treatment of diabetes with rosiglitazone and insulin
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20020045649A1 (en) * 1997-07-18 2002-04-18 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
EP1277753A1 (de) 1999-04-23 2003-01-22 SmithKline Beecham plc Thiazolidindionderivat und seine Verwendung als Antidiabetikum
AR023561A1 (es) 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
DE60037602T2 (de) 1999-04-23 2009-01-08 Smithkline Beecham P.L.C., Brentford Herstellung einer polymorphen Form eines Thiazolidindionderivates
NZ525498A (en) 2000-09-26 2004-11-26 Reddys Lab Ltd Dr Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation

Also Published As

Publication number Publication date
NZ515163A (en) 2004-02-27
EP1903043A1 (de) 2008-03-26
CO5170424A1 (es) 2002-06-27
CN1355801A (zh) 2002-06-26
JP2002543075A (ja) 2002-12-17
EA200101119A1 (ru) 2002-04-25
WO2000064892A3 (en) 2001-01-25
AR023564A1 (es) 2002-09-04
CY1107238T1 (el) 2012-11-21
CA2370258A1 (en) 2000-11-02
KR20020028873A (ko) 2002-04-17
BG65427B1 (bg) 2008-07-31
HRP20010773B1 (en) 2005-06-30
NO320589B1 (no) 2005-12-27
RS50114B (sr) 2009-03-25
ATE247653T1 (de) 2003-09-15
NO20015149L (no) 2001-12-17
SK286423B6 (sk) 2008-09-05
HUP0200929A3 (en) 2004-03-29
EP1284268A1 (de) 2003-02-19
AU4130600A (en) 2000-11-10
US6815457B1 (en) 2004-11-09
SK14912001A3 (sk) 2002-02-05
MY128007A (en) 2007-01-31
EP1173434A2 (de) 2002-01-23
TR200103061T2 (tr) 2002-05-21
DE60004658D1 (de) 2003-09-25
WO2000064892A2 (en) 2000-11-02
BG106119A (en) 2002-05-31
MA26785A1 (fr) 2004-12-20
MXPA01010820A (es) 2002-06-04
HUP0200929A2 (en) 2002-08-28
HK1045154A1 (en) 2002-11-15
DK1284268T3 (da) 2008-04-28
AR023568A1 (es) 2002-09-04
PT1284268E (pt) 2008-03-10
US20040092555A1 (en) 2004-05-13
HK1045154B (en) 2004-06-25
DZ3155A1 (fr) 2000-11-02
AP1495A (en) 2005-11-30
CN1208335C (zh) 2005-06-29
EP1173434B1 (de) 2003-08-20
YU75201A (sh) 2004-09-03
DK1173434T3 (da) 2003-12-08
EP1284268B1 (de) 2007-12-26
BR0009934A (pt) 2002-06-04
UA67843C2 (uk) 2004-07-15
EA004534B1 (ru) 2004-06-24
ES2204557T3 (es) 2004-05-01
UY26120A1 (es) 2000-12-29
ATE382046T1 (de) 2008-01-15
HRP20010773A2 (en) 2002-10-31
PE20010040A1 (es) 2001-03-10
IL146110A0 (en) 2002-07-25
TW591027B (en) 2004-06-11
ES2298327T3 (es) 2008-05-16
AU765498B2 (en) 2003-09-18
PL351686A1 (en) 2003-06-02
DE60004658T2 (de) 2004-06-24
NO20015149D0 (no) 2001-10-22
CZ20013799A3 (cs) 2002-04-17
OA11871A (en) 2006-03-27
PT1173434E (pt) 2003-12-31
HK1055293A1 (en) 2004-01-02
DE60037602T2 (de) 2009-01-08
KR100744359B1 (ko) 2007-07-30

Similar Documents

Publication Publication Date Title
DE60037602D1 (de) Herstellung einer polymorphen Form eines Thiazolidindionderivates
DE60037395D1 (de) Herstellung eines halbleiter-bauelementes
PL395097A1 (pl) Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu
DE60008859D1 (de) Verbindungsstruktur einer teleskopstange
DE60029295D1 (de) Verfahren zur Herstellung eines basischen wasserabsorbierenden Mittels
SI1147075T1 (sl) Postopek za pripravo L-fenilefrin hidroklorida
DE69916232D1 (de) Zusammensetzung zur Herstellung einer Metall-Keramik-Beschichtung
DE60037443D1 (de) Herstellung eines kondensators durch bildung einer mit halbkugel-korn-silizium versehenen siliziumelektrode
DE10081019T1 (de) Verfahren zur Herstellung einer Kautschukzusammensetzung
DE60109545D1 (de) Verfahren zur Herstellung einer Aromazusammensetzung auf Pilzbasis
DE60003470D1 (de) Verfahren zur Herstellung eines Triarylamindimeres
MA26844A1 (fr) Nouveaux derives de la thiazolidinedione comme agents antidiabetiques
DE69920553D1 (de) Flansch eines hohlen Gegenstandes
EE05609B1 (et) Dibensotiasepiiniderivaatide valmistamismeetod
NO20000965L (no) FremgangsmÕte for fremstilling av veksthormon-utskillende forbindelser
DE50009162D1 (de) Rotormast eines hubschraubers
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
FI963467L (fi) Tiatsolidiinidionijohdannaisia veren liikasokerisuuden vastaisina aineina
DE60133746D1 (de) Tartratsalze eines thiazolidinedione derivats
DE59803460D1 (de) Vorbereitung eines watteendes einer wattebahn
DE60021956D1 (de) Herstellung einer Gasflasche
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks
ATE384059T1 (de) Tartratsalze eines thiazolidinedione derivats
DE60119188D1 (de) Verfahren zur Herstellung einer Epoxycyclododecan-Verbindung
SI1284268T1 (sl) Priprava polimorfnih oblik derivatov tiazolidinedion-a

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: BLACKLER, PAUL DAVID JAMES, NEAR LEIGH TONBRID, GB

Inventor name: GILES, ROBERT GORDON, NEAR LEIGH TONBRIDGE, KE, GB

Inventor name: SASSE, MICHAEL JOHN, NEAR LEIGH TONBRIDGE, KEN, GB

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee